AC

Ajad Chourasiya

Active Director Director DIN 09028422
DIN 09028422 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Ajad Chourasiya

Data last updated:

Ajad Chourasiya is a Director at Jas Genetic Private Limited (since 2021). The company operates in Chemicals. Jas Genetic Private Limited reported revenue of ₹73.9 Lakh (FY 2025).

DIN 09028422
Primary Designation Director
Industry Chemicals
First Appointment 13 Jan 2021
Oldest Company Age 5 yrs
Largest company Jas Genetic Private Limited · ₹73.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jas Genetic Private Limited U24290MP2021PTC054487
Director13 Jan 20212021₹73.9 Lakh (FY 2025)Active

Board colleagues of Ajad Chourasiya

NameDINCompanyDesignation
Rama Chourasiya10041132Jas Genetic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jas Genetic Private Limited
Premium access

Shareholding and investment profile for Ajad Chourasiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajad Chourasiya

Ajad Chourasiya currently holds 1 directorship: Jas Genetic Private Limited (Director, since 13 Jan 2021, revenue ₹73.9 Lakh (FY 2025)).

Ajad Chourasiya was first appointed on 13 Jan 2021 as Director at Jas Genetic Private Limited.

The current boards of Ajad Chourasiya's companies include Rama Chourasiya (Jas Genetic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available